Sign in →

Test Code ALKP Alkaline Phosphatase (ALP)

Additional Codes

EPIC LAB4008

Clinical Significance

Alkaline phosphatase in serum consists of four structural genotypes: the liver‑bone‑kidney type, the intestinal type, the placental type and the variant from the germ cells. It occurs in osteoblasts, hepatocytes, leukocytes, the kidneys, spleen, placenta, prostate and the small intestine. The liver‑bone‑kidney type is particularly important. 

 

A rise in the alkaline phosphatase occurs with all forms of cholestasis, particularly with obstructive jaundice. It is also elevated in diseases of the skeletal system, such as Paget’s disease, hyperparathyroidism, rickets and osteomalacia, as well as with fractures and malignant tumors. A considerable rise in the alkaline phosphatase activity is sometimes seen in children and juveniles. It is caused by increased osteoblast activity following accelerated bone growth. 

 

Source: Roche Cobas ALP2 Method Sheet Version 2.0 2022-09

Methodology

Colorimetric test (Roche Cobas c503/c303)

Sample Type

Preferred Sample Type
Light green top - Plasma

 

Acceptable Sample Type(s)
Dark green top - Plasma
Yellow top - Serum
Red top - Serum

Centrifuge: Yes

Specimen Minimum Volume

55 uL with insert cup

Specimen Stability

Temperature Time
Ambient (20-25°C) 7 days
Refrigerated (4-8°C) (store) 7 days
Frozen (-20°C) 2 months

Separate plasma or serum from cells within 2 hours.

Reference Ranges

Normal Range
Male 40 - 129 U/L
Female 35 - 104 U/L

 

Technical Range
5 - 1,200 U/L

 

Rejection Criteria

Hemolysis Index >200
Icteric Index >60
Lipemia Index >2,000, ultracentrifuge

 

Availability

Performed STAT
24/7 Yes

 

Performing Laboratory

MultiCare Yakima Memorial Hospital Laboratory

MultiCare Cancer Care (NSL)

Lab Department

Chemistry

CPT Code

84075

LOINC

6768-6 ALP [Catalytic activity/Vol]